Assessing the interferome in novel, purpose-driven bat-derived cells
评估新型、目的驱动的蝙蝠来源细胞中的干扰素
基本信息
- 批准号:10451405
- 负责人:
- 金额:$ 17.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-09 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAgricultureAnimalsBiological AssayBrainCell Culture TechniquesCell LineCellsChiropteraClinicalClone CellsCollectionCommunitiesComparative StudyCompetenceComplement ReceptorCoronavirusCritical PathwaysDataDevelopmentDiseaseFeasibility StudiesFutureGenus PteropusGoalsHumanImmunologicsImmunologyInfectionInfection ControlInnate Immune ResponseInterferon Type IInterferonsKidneyKnowledgeLaboratoriesLightLiverLungMediatingMiddle East Respiratory Syndrome CoronavirusModelingMolecularNatural ImmunityNipah VirusPathway interactionsPoly I-CPredispositionPrimary Cell CulturesProcessRNA VirusesReagentRecombinant CytokinesRecombinantsReporterResearchResearch PersonnelResistanceRousettusSARS coronavirusSendai virusSpleenTestingTherapeuticTissuesTropismVesicular stomatitis Indiana virusViralVirusVirus DiseasesVirus ReceptorsVirus ReplicationZoonosesantiviral immunitybasebat-bornebetacoronaviruscell culture collectioncell immortalizationcell typecytokineexperienceglobal healthin vitro Modelin vivoinnate immune pathwaysnew therapeutic targetnovelnovel therapeuticsparticlepathogenpathogenic viruspublic repositoryresponsetooltranslational study
项目摘要
Assessing the interferome of novel, purpose-driven bat-derived cells
SUMMARY/ABSTRACT
Over the last decade, bats have emerged as intriguing mammalian reservoirs of emerging high
impact viruses that cause severe disease in humans and agricultural animals. However, bats that are
naturally or experimentally infected with these viruses do not develop clinical signs of disease. Thus,
understanding how bats tolerate virus infections may allow us to develop novel drugs or identify new
drug targets for alternate mammalian species, such as humans. In spite of recent advances in bat
immunology, studies have largely relied on cell culture models from selected bat species, limiting our
understanding of this diverse mammalian order. The order Chiroptera is made up of over 1420 species
of bats, and data from a handful of bats do not represent evolutionary adaptations in all bats. In addition,
these reagents are not available on public repositories making it hard for the research community to
pursue this intriguing and growing field of research.
For our proposal, we propose to develop novel bat reagents, including primary and immortalized
cells from five major bat species, Rousettus aegyptiacus, Pteropus alecto, Eptesicus fuscus, Artibeus
jamaicensis, and Carollia perspicillata, representing bats that currently exist in research colonies,
making future in vivo translational studies feasible and logical. Data from selected bats, such as
Rousettus, Pteropus and Eptesicus bats suggest that bat cells have evolved adaptations in their
cytokine responses to better tolerate virus infections relative to humans. Type I interferon (IFN)
responses are the first line of mammalian antiviral defense, and although type I IFNs and their
downstream effects have been studied in selected bat cells, global cellular responses and the full range
of IFN-mediated antiviral effects or the ‘interferome’ remain elusive. For this project, we shall use our
diverse bat cell types, derived from multiple bat species, to identify and delineate evolutionarily
conserved and unique bat-specific IFN responses. Results from our study will shed light on intriguing
questions around the ability of bats to control infection with zoonotic RNA viruses, along with making
important discoveries on evolutionary adaptations in the mammalian type I IFN pathway. Importantly,
our research will generate critical bat reagents, such as primary cells, cell lines, recombinant cytokines
and molecular assays that will facilitate the development of larger collaborative projects to study bat
immunology.
评估新型、目的驱动的蝙蝠源细胞的干扰素组
总结/摘要
在过去的十年里,蝙蝠已经成为一种有趣的哺乳动物,
影响导致人类和农业动物严重疾病的病毒。然而,
自然或实验感染这些病毒不会产生疾病的临床症状。因此,在本发明中,
了解蝙蝠如何耐受病毒感染可能有助于我们开发新药或发现新的
替代哺乳动物物种(例如人类)的药物靶点。尽管最近蝙蝠的进步
免疫学,研究在很大程度上依赖于选定的蝙蝠物种的细胞培养模型,限制了我们的研究。
了解这种多样的哺乳动物秩序。翼手目由1420多个物种组成
蝙蝠的进化适应性,来自少数蝙蝠的数据并不代表所有蝙蝠的进化适应性。此外,本发明还提供了一种方法,
这些试剂在公共储存库中不可用,使得研究团体很难
追求这个有趣的和不断增长的研究领域。
对于我们的建议,我们建议开发新的蝙蝠试剂,包括初级和永生化
来自五种主要蝙蝠物种的细胞,Rousettus aegyptiacus、Pteropus alecto、Eptesicus fuscus、Artibeus
jamaicensis和Aprilia perspicillata,代表目前存在于研究群体中的蝙蝠,
使得未来的体内转化研究可行且合乎逻辑。数据来自选定的蝙蝠,如
Rousettus、Pteropus和Eptesicus蝙蝠表明,蝙蝠细胞在它们的进化过程中已经进化出了适应性。
细胞因子应答,以相对于人类更好地耐受病毒感染。I型干扰素(IFN)
免疫应答是哺乳动物抗病毒防御的第一道防线,尽管I型IFN及其
下游效应已在选定的蝙蝠细胞,全球细胞反应和全方位的研究
干扰素介导的抗病毒作用或“干扰素组”仍然难以捉摸。在这个项目中,我们将使用我们的
不同的蝙蝠细胞类型,来自多个蝙蝠物种,以确定和描绘进化
保守和独特的蝙蝠特异性IFN应答。我们的研究结果将揭示有趣的
关于蝙蝠控制人畜共患RNA病毒感染的能力的问题,沿着
哺乳动物I型IFN途径进化适应的重要发现。重要的是,
我们的研究将产生关键的蝙蝠试剂,如原代细胞,细胞系,重组细胞因子,
和分子分析,这将有助于更大的合作项目的发展,研究蝙蝠
免疫学
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arinjay Banerjee其他文献
Arinjay Banerjee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arinjay Banerjee', 18)}}的其他基金
Assessing the interferome in novel, purpose-driven bat-derived cells
评估新型、目的驱动的蝙蝠来源细胞中的干扰素
- 批准号:
10569631 - 财政年份:2022
- 资助金额:
$ 17.02万 - 项目类别:
相似海外基金
COUSIN: Crop Wild Relatives utilisation and conservation for sustainable agriculture
表弟:作物野生近缘种的利用和保护以实现可持续农业
- 批准号:
10090949 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
EU-Funded
Research Infrastructure: Mid-scale RI-1 (MI:IP): X-rays for Life Sciences, Environmental Sciences, Agriculture, and Plant sciences (XLEAP)
研究基础设施:中型 RI-1 (MI:IP):用于生命科学、环境科学、农业和植物科学的 X 射线 (XLEAP)
- 批准号:
2330043 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Cooperative Agreement
REU Site: Controlled Environment Agriculture (CEAfREU)
REU 站点:受控环境农业 (CEAfREU)
- 批准号:
2349765 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Standard Grant
I-Corps: Intelligent Hydroponics Growing Platform for Sustainable Agriculture
I-Corps:可持续农业的智能水培种植平台
- 批准号:
2345854 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Standard Grant
NSF Engines: North Dakota Advanced Agriculture Technology Engine
NSF 发动机:北达科他州先进农业技术发动机
- 批准号:
2315315 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Cooperative Agreement
In Search of Future Farmers: Comparative Research on Young People's Exit from Agriculture in Rural Indonesia, Japan and Nepal
寻找未来农民:印度尼西亚、日本和尼泊尔农村年轻人退出农业的比较研究
- 批准号:
23K22187 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Novel Biofertiliser for Sustainable Agriculture: Tackling Phosphorus Crisis
用于可持续农业的新型生物肥料:解决磷危机
- 批准号:
IM240100158 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Mid-Career Industry Fellowships
Rural Development and Community Resiliency Through Agriculture Heritage Tourism
通过农业遗产旅游促进农村发展和社区复原力
- 批准号:
23K21819 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Arboricrop: next generation agriculture using real-time information from trees crops
Arboricrop:利用树木作物实时信息的下一代农业
- 批准号:
10087410 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Collaborative R&D
Advancing Controlled Environment Agriculture (CEA) with Dynamic LED Lighting Systems and Artificial Intelligence
利用动态 LED 照明系统和人工智能推进受控环境农业 (CEA)
- 批准号:
BB/Z514330/1 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Research Grant